Company Overview
- Website
- lyticatx.com
- Employees
- 11
- Industry
- BioTech/Drugs
- SIC Code
-
8731 - Commercial Physical and Biological Research
Financials & Stats
Revenue
$3B
Recent News & Media
Impact of Age on Autologous Stem Cell Transplantation Outcomes for AL Amyloidosis
- Dec 9, 2024
- sciencedirect.com
Multi-Omic Single-Cell Characterization of Paired and Serial Samples in Responding and Non-Responding Patients Receiving BCMA Bispecific Antibody Therapy for Multiple Myeloma
- Nov 5, 2024
- sciencedirect.com
Elucidation of Molecular Mechanisms of Iberdomide and Mezigdomide Resistance in Cell Line Models of Multiple Myeloma
- Nov 5, 2024
- sciencedirect.com
Unveiling Clinical Potential: Exploring Cytogenomic Aberrations through Optical Genomic Mapping in Multiple Myeloma
- Nov 5, 2024
- sciencedirect.com
The Anti-BCMA Antibody-Drug Conjugate Hdp-101 with a Novel Amanitin Payload Shows Promising Initial First in Human Results in Relapsed Multiple Myeloma
- Nov 5, 2024
- sciencedirect.com
Association of Social Determinants of Health Status (SDOH) and Ethnicity with Survival in Multiple Myeloma Patients
- Nov 5, 2024
- sciencedirect.com
Companies Similar to Lytica Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Lytica Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | 2 | Cambridge, MA | 2005 | |
| 3M | 7 | New York, NY | 2008 | |
| 3M | 3 | New York, NY | ||
| 3M | 2 | Knoxville, TN | 2004 | |
| 3M | 35 | Austin, TX |